THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
ARAP, WADIH,MINTZ, PAUL, J.,PASQUALINI, RENATA
申请号：
EP09767865
公开号：
EP2303913A4
申请日:
2009.06.19
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
Provided are methods and compositions for selectively targeting CRKL through the use of targeting peptides. Selective targeting of secreted CRKL through the use of a targeting peptide may be used, for example, in the treatment of cancer to deliver a chemotherapeutic compound, fusion protein, or fusion construct to a cancer cell or tissue.
